Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021


HomeEXECUTIVESRadcliffe Group Appoints Dr. Peter O'Kane New Editor-in-Chief of Interventional Cardiology Review and Opens Journal to Original Research Through Its Title Change (ICR3)

Radcliffe Group Appoints Dr. Peter O’Kane New Editor-in-Chief of Interventional Cardiology Review and Opens Journal to Original Research Through Its Title Change (ICR3)

Radcliffe Group, a STM publisher and digital media producer of cardiovascular, renal, and metabolic content has announced Dr. Peter O’Kane as the new editor-in-chief of their journal, Interventional Cardiology: Reviews, Research, and Resources.

Dr. O’Kane was appointed as a consultant interventional cardiologist at the Royal Bournemouth Hospital in July 2007 and has performed more than 7,000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification, and chronic occlusions.

He is committed to teaching and has trained many physicians both in the UK and internationally in devices such as rotational and laser atherectomy and developing technical skills such as those involved in bifurcation stenting and coronary imaging utilization. He has presented at many cardiology conferences and performed as a live case operator. He has contributed to 30 global research studies as a local principal investigator with a high provision of randomized patients and has co-authored more than 50 manuscripts in addition to 10 book chapters.

With such a keen interest in clinical and academic cardiology, Dr. O’Kane is very excited to take this position. “It is a great privilege to accept the position of EiC for ICR3 and work alongside a fantastic team of clinicians, academics, and editors in this well-established publishing house. I will bring my cardiology experience to build on the strong foundations of the journal and develop strategies to promote original research submission whilst maintaining the recognized high quality of reviews and clinical resources that have been synonymous with Radcliffe Group and have undoubtedly guided patient care across the world”, said Dr. O’Kane.

Radcliffe Cardiology would like to thank Dr. Simon Kennon for his editorship of ICR over the last seven years and wish him well. He will continue to remain involved with the ICR journal as an editorial board member, supporting the incumbent Editor-in-Chief.

At the same time, ICR is changing its title to Interventional Cardiology: Reviews, Research, Resources (ICR3) and has now opened to receive submissions of original research. This is the next step in the journal’s development, and we are thrilled about the exciting opportunities to come.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy